Posted inBiotechnology
AI Clocks Point to an Oral Microbe That Slows Aging in Humans, Worms and Mice
A common bacterium that lives quietly on the human tongue may hold one of the most surprising clues yet in…
Posted inBiotechnology
Strange Metals Traced to Bad Metallicity and Quantum Statistics of Charge Carriers
Strange metals are among the most perplexing states of matter in modern condensed matter physics. Found most famously in the…
Posted inBiotechnology
How Parents’ Moral Excuses May Steer Teens Toward Alcohol and Tobacco
Every parent has moments when a small transgression seems forgivable. But what happens when that habit of excusing wrongdoing becomes…
Posted inBiotechnology
Health Claims on Food Packaging Often Outrun the Nutrition Inside
Walk down any supermarket aisle and the packages seem to be shouting about wellness. More than half of new food…
Posted inBiotechnology
Gut Bacteria Turn Sugarcane Waste into Fuel Gold in Biorefinery Breakthrough
The world’s two largest biofuel industries—bioethanol and biodiesel—generate staggering mountains of waste every year. Sugarcane mills in Brazil alone produce…
Posted inBiotechnology
Machine Learning Turns RISC-V Chips Into Their Own Hardware Attack Detectors
Modern processors keep secrets badly. The Meltdown and Spectre revelations of 2018 showed the world that the innermost machinery of…
Posted inBiotechnology
Tiny Finger, Big Lesson: Ultrasound Reveals Hidden Toddler Fracture X-rays Missed
When an 18-month-old girl arrived at the hospital with a swollen left middle finger and a noticeably limited range of…
Posted inBiotechnology
China’s Henlius carves out $440M T-cell engager deal with Amberstone
Fosun Pharma subsidiary Henlius Biotech has signed a $440 million biobucks deal with California-based Amberstone Biosciences to work on T-cell…
Posted inBiotechnology
Acadia misses mark in Alzheimer’s but concludes phase 3 ‘absolutely worth’ pursuing
Acadia Pharmaceuticals’ phase 2 Alzheimer’s disease trial has missed its primary endpoint, but the company and analysts alike saw enough encouraging…
Posted inBiotechnology
Merck sees pivotal victory for $3B eye disease prospect
Merck & Co.’s Brunello trial has hit its primary endpoint, shedding light on the effects of a trispecific diabetic macular edema…